北大医药(000788.SZ)发布前三季度业绩，归母净利润1.36亿元，增长4.31%

Core Viewpoint - The company reported a decline in revenue for the first three quarters of 2025, while net profit showed a slight increase year-on-year [1] Financial Performance - The company's operating revenue for the first three quarters was 1.231 billion yuan, a year-on-year decrease of 19.76% [1] - Net profit attributable to shareholders of the listed company was 136 million yuan, reflecting a year-on-year increase of 4.31% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 126 million yuan, a year-on-year decrease of 2.66% [1] - Basic earnings per share were 0.2282 yuan [1]